Cardinal Health is trading at $231.13, up 4.12%, after announcing a binding letter of intent to extend its pharmaceutical distribution agreement with CVS Health through June 30, 2032. - The extension retains the current scope of services and secures a major customer relationship for several more years. - Cardinal Health reaffirmed its fiscal 2027 and long-term adjusted EPS growth outlooks. - Healthcare shares are down 1.33%, while Cardinal Health closed at $222.50 on September 30; the sector trend does not explain the gain.